Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2025-08-08 00:00:00 ET · period of report 2025-08-08 · accession 0001062993-25-013981 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-08 | 2025-08-08 | ENTA | Rottinghaus Scott T. | Chief Medical Off | F - Tax | $6.99 | -2,217 | 22.6K | -9% | -$15.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-08 | F | D | 2,217 | $6.99 | 22,590 | D | — | — | (F1) Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022. |